Montserrat vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy
Montserrat
0 patients
in 2019
Yemen
0 patients
in 2020
Montserrat rank
141st
Yemen rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Montserrat
- Yemen
How they compare
Montserrat currently reports 0 patients against 0 patients in Yemen, a difference of 0 patients.
Across all 8 years both countries report, Yemen has been ahead every year.
Montserrat ranks 141st and Yemen ranks 141st of 183 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montserrat | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 0 patients | 7 patients | 7 patients | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Montserrat or Yemen?
- Montserrat, at 0 patients against 0 patients in Yemen as of 2019.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Montserrat and Yemen?
- 0 patients, with Montserrat ahead.
- How many years of comparable data are there for Montserrat and Yemen?
- 8 years are reported by both, from 2005 to 2018.
- How do Montserrat and Yemen rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Montserrat ranks 141st and Yemen ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.